Membrane Protein-Based CAR-T Therapy Development Service
- CAR-T Therapy Development: Supports clients in screening and validating membrane protein targets to optimize CAR-T cell specificity, accelerating research and development in cancer immunotherapy.
- Antibody Screening: Facilitates the discovery and development of specific antibodies by enabling the screening and validation of membrane proteins, advancing early-stage immunotherapy product development.
- Immune Monitoring and Off-Target Effect Evaluation: Enhances the safety of CAR-T therapy through off-target effect analysis, helping to minimize unintended interactions and improve therapeutic precision.
Membrane Protein-Based CAR-T Therapy Development Service refers to a specialized technical service that supports the development of CAR-T therapy through systematic screening, functional validation, and optimization of membrane protein targets. The core objective of this service is to design and develop highly specific CAR-T cells with minimal off-target effects by identifying and analyzing membrane protein-based targets-ultimately enhancing the efficacy and safety of tumor immunotherapy.
With the rapid advancement of cancer immunotherapy, particularly the clinical success of CAR-T (Chimeric Antigen Receptor T-cell) therapies in treating hematologic malignancies, research and application of CAR-T have increasingly expanded into the realm of solid tumors. The success of CAR-T therapy depends on its ability to accurately and specifically target tumor cells, which hinges critically on the selection of suitable target antigens. Membrane proteins, as key components of the cell membrane, play essential biological roles in cell recognition, signal transduction, and metabolic regulation, making them ideal candidates for CAR-T targeting.
Due to their unique structural and functional properties, membrane proteins serve as important cell-surface antigens and are highly promising targets for cancer immunotherapy. In particular, differential expression of membrane proteins between tumor and normal cells provides significant potential for precision-targeted therapies. The development of CAR-T therapy based on membrane proteins relies on the comprehensive screening, validation, and optimization of these targets, aiming to deliver more precise treatment strategies, reduce off-target toxicity, and improve the specificity and safety of CAR-T therapeutics.
Zheng Z. et al. Cancers. 2023.
Figure 1. The evolution of chimeric antigen receptors (CAR)-T cells.
Services at MtoZ Biolabs
MtoZ Biolabs offers a Membrane Protein-Based CAR-T Therapy Development Service that assists clients in developing efficient and precise CAR-T therapy through membrane protein target selection and optimization. By integrating advanced mass spectrometry, immunoaffinity capture techniques, and off-target effect evaluation, we support the development of CAR-T therapies targeting specific membrane proteins-enhancing the precision and safety of tumor immunotherapy. This service provides strong support for both research and clinical translation in cancer immunotherapy. The core components of MtoZ Biolabs' service include:
Membrane Protein Target Screening
Utilizing mass spectrometry, genomics, and proteomics technologies to screen for membrane proteins with high specificity and strong surface expression on tumor cells.
Membrane Protein Purification
Applying advanced techniques for membrane protein extraction to preserve physiological activity and structural integrity, ensuring stable and functional targets for CAR-T cell recognition.
CAR-T Cell and Membrane Protein Binding Validation
Utilizing techniques such as immunoaffinity capture and phage display to validate the binding capacity and specificity between membrane proteins and CAR-T cells.
Off-Target Risk Assessment
Employing membrane protein microarray technology to detect potential off-target effects of CAR-T cells and comprehensively analyze their unintended interactions with membrane proteins from non-tumor tissues.
Service Advantages
1. High-Quality Membrane Protein Preparation
Utilizes advanced membrane protein extraction techniques to ensure functional activity and structural stability, delivering membrane proteins with high purity and excellent stability.
2. Off-Target Analysis and Optimization
Provides high-precision off-target analysis services to help clients minimize off-target effects in CAR-T therapy and enhance treatment safety.
3. Customized Data Analysis and Reporting
Offers tailored data analysis and reporting based on client needs, enabling better interpretation of experimental results and optimized CAR-T cell design.
4. Broad Applications
This service is not only suitable for CAR-T therapy development but also applicable to antibody screening, vaccine development, and other areas of biopharmaceutical research.
Applications
Examples of applications for Membrane Protein-Based CAR-T Therapy Development Service:
Related Services
Membrane and Membrane Protein Extraction Service
How to order?
